Skip to main content
. 2021 May 27;48(7):2295–2305. doi: 10.1007/s00259-021-05401-4

Fig. 3.

Fig. 3

Distribution of SUVR values for [18F]flortaucipir, [18F]RO948, and [18F]MK6240 across data-driven ROIs. The notch in the box-and-whisker plots indicates the 95% confidence interval for the median. (A) The regions that best separated AD dementia from CU individuals (parahippocampus and inferior temporal cortex) and those diagnosed with non-AD neurodegenerative disorders (entorhinal cortex, amygdala, parahippocampus, and inferior temporal cortex) using [18F]flortaucipir PET. (B) The regions that best separated AD dementia from CU individuals (entorhinal cortex and amygdala) and those diagnosed with non-AD neurodegenerative disorders (entorhinal cortex, amygdala, parahippocampus, fusiform gyrus, and inferior temporal cortex) using [18F]RO948. (C) The regions that best separated AD dementia from CU individuals (fusiform gyrus, inferior temporal cortex, middle temporal gyrus) and those diagnosed with non-AD neurodegenerative disorders (entorhinal cortex, amygdala, the inferior temporal cortex, the banks of the superior temporal sulcus, and the fusiform gyrus) using [18F]MK6240